Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson's Disease Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03562494
What this trial is testing

VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1)

Who this might be right for
Parkinson's Disease
Neurocrine Biosciences 14
Large-scale testing (Phase 3)Study completedNCT01556165
What this trial is testing

Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China

Who this might be right for
Parkinson's Disease
H. Lundbeck A/S 130
Not applicableStudy completedNCT03037463
What this trial is testing

Measuring Parkinson's Disease With Tear Fluid

Who this might be right for
Idiopathic Parkinson Disease
University of Southern California 205
Testing effectiveness (Phase 2)Study completedNCT01092065
What this trial is testing

Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia

Who this might be right for
Parkinson's Disease
Novartis 23
Large-scale testing (Phase 3)Active Not RecruitingNCT02339064
What this trial is testing

Infusion of Apomorphine: Long-term Safety Study

Who this might be right for
Idiopathic Parkinson's Disease
MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals 99
Testing effectiveness (Phase 2)Study completedNCT00491998
What this trial is testing

PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets

Who this might be right for
Parkinson's Disease
Vernalis (R&D) Ltd 27
Post-approval studies (Phase 4)Active Not RecruitingNCT07483398
What this trial is testing

EFficacy and safEty of cRisugabalin on nocipLastic paIn in Patients With Parkinson's Disease (RELIEF-PD): a Multicentre, Double-blind, Randomised Controlled Trial

Who this might be right for
PARKINSON DISEASE (Disorder)
Guangdong Provincial People's Hospital 166
Large-scale testing (Phase 3)Study completedNCT00955045
What this trial is testing

A Long-Term, Safety Study With a Flexible Dose Range of KW-6002 in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy

Who this might be right for
Parkinson's Disease
Kyowa Kirin, Inc.
Not applicableLooking for participantsNCT07145190
What this trial is testing

SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment

Who this might be right for
Parkinson Disease
Bial - Portela C S.A. 90
Not applicableLooking for participantsNCT07227896
What this trial is testing

Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease

Who this might be right for
Parkinson's Disease
AbbVie 100
Not applicableUnknownNCT02419768
What this trial is testing

Effects of Exercise on Long-Range Autocorrelations in Parkinson's Disease

Who this might be right for
Parkinson's Disease
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 50
Testing effectiveness (Phase 2)Study completedNCT04575259
What this trial is testing

OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001

Who this might be right for
Parkinson Disease Dementia
Anavex Life Sciences Corp. 132
Not applicableStudy completedNCT01465360
What this trial is testing

Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center

Who this might be right for
Alzheimer's DiseaseMild Cognitive ImpairmentVascular Dementia+4 more
Exonhit 160
Not applicableStudy completedNCT01003535
What this trial is testing

Quantification of Cerebral Cholinergic Function in Parkinson´s Disease by Means of Nuclear Medicine Methods

Who this might be right for
Parkinson´s DiseaseAcetylcholineSPECT
Universität des Saarlandes 25
Not applicableStudy completedNCT06246747
What this trial is testing

The Use of Telerehabilitation to Improve Movement Outcomes for Patients With Parkinson Disease

Who this might be right for
Parkinson Disease
Wizecare 19
Early research (Phase 1)Study completedNCT00063284
What this trial is testing

Investigating the Safety of srTMS in the Treatment of Parkinson's Disease

Who this might be right for
Parkinson Disease
National Institute of Neurological Disorders and Stroke (NINDS) 10
Not applicableUnknownNCT05142085
What this trial is testing

Efficacy of Nano-PSO in Parkinson's Disease.

Who this might be right for
Parkinson Disease
Distribuidora Biolife SA de CV 170
Not applicableLooking for participantsNCT06350617
What this trial is testing

Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD Patients

Who this might be right for
Parkinson's Disease and Parkinsonism
Samsung Medical Center 60
Not applicableStudy completedNCT03608228
What this trial is testing

Invasive Approach to Model Human Cortex-Basal Ganglia Action-Regulating Networks

Who this might be right for
Parkinson's Disease Patients Undergoing Deep Brain Stimulation (DBS) Surgery
University of California, Los Angeles 27
Not applicableStudy completedNCT04699617
What this trial is testing

The Feasibility and Efficacy of an Immersive Virtual Reality Software in Parkinson's Disease Patients

Who this might be right for
Parkinson Disease
Campus Neurológico Sénior 30
Next Page